Clinical Trials
17 trialsNCT07528417 2026-04-22
MYELO-CAN:ABX
University of Manitoba
Phase 2 Not yet recruiting
NCT07320534 2026-01-08
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
Gadjah Mada University
Phase 4 Not yet recruiting
NCT03594149 2026-01-02
AZABAC
Centre Henri Becquerel
Phase 3 Completed
NCT04502095 2025-08-03
Prophylactic Antibiotics for Urinary Tract Infections After Robot-Assisted Radical Cystectomy
Roswell Park Cancer Institute
Phase 4 Completed
NCT06216639 2024-02-09
Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection
National Institute of Public Health, Slovenia
Unknown
NCT06049758 2023-09-22
D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy
General Committee of Teaching Hospitals and Institutes, Egypt
Phase NA Not yet recruiting
NCT05393505 2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4 Unknown
NCT04204382 2021-02-25
Effects of CKI for Oral Mucositis Caused by Radiotherapy for Head and Neck Cancer
Shanxi Zhendong Pharmacy Co., Ltd
Phase 4 Unknown
NCT01371656 2020-12-07
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Children's Oncology Group
Phase 3 Completed
NCT04212403 2020-02-24
Prophylaxis001
Jessa Hospital
Phase NA Completed
NCT03159845 2020-01-07
ZENITH
Azienda Ospedaliero, Universitaria Pisana
Phase 2 Completed
NCT03003273 2019-02-01
DALFEN
All India Institute of Medical Sciences
Phase 3 Terminated
NCT02757365 2016-05-02
Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer
West China Hospital
Phase 4 Unknown
NCT00250718 2015-08-03
Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach
New Mexico Cancer Research Alliance
Phase 2 Terminated
NCT00020865 2013-12-19
Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00005590 2013-08-02
Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma
National Cancer Institute (NCI)
Phase 3 Completed
NCT00215007 2007-11-30
Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)
Charite University, Berlin, Germany
Phase 2/3 Unknown